Skip to main content

Table 1 Expression of lnc-SNHG1 in serous epithelial ovarian cancer tissues

From: Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer

 

lnc-SNHG1

  
 

Total cases

High expression (n = 37)

Low expression (n = 58)

χ2

P

Age (year)

n

n

%

n

%

0.074

0.786

Postmenopausal (< 50)

42

17

40.48

25

59.52

  

Premenopausal (50)

53

20

37.74

33

62.26

  

Tumor stage (FIGO)

     

8.435

0.015

I-II

21

4

19.05

17

80.95

  

III

45

16

35.56

29

64.44

  

IV

29

17

58.62

12

41.38

  

Histological grade (n = 88)

     

6.529

0.011

H

72

34

47.22

38

52.78

  

L

16

2

12.50

14

87.50

  

Nodal status (n)

     

13.323

0.0001

Negative

60

15

25.00

45

75.00

  

Positive

35

22

62.86

13

37.14

  

Tumor diameter (cm)

     

0.343

0.842

< 10 cm

30

12

40.00

18

60.00

  

10–20 cm

58

23

39.66

35

60.34

  

> 20 cm

7

2

28.57

5

71.43

  

Chemotherapy

     

31.148

0.0001

Chemoresistance

32

25

78.13

7

21.87

  

Chemosensitivity

63

12

19.05

51

80.95

  

Metastasis

     

25.499

0.0001

Y

19

17

89.47

2

10.53

  

N

76

20

26.32

56

73.68